Lv4
410 积分 2026-08-12 加入
RIVER-mPDAC: A phase 2b/3 study of ponsegromab for the treatment of cachexia in patients with metastatic pancreatic ductal adenocarcinoma receiving first-line chemotherapy
6天前
已关闭
Phase 2 study to assess the efficacy, safety, and tolerability of the GDF-15 inhibitor ponsegromab in patients with cancer cachexia
6天前
已完结
LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program
6天前
已关闭
Stage-specific risk factors of cardiometabolic multimorbidity: A systematic review and meta-analysis from incidence to mortality
27天前
已完结
Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer
1个月前
已完结
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk
1个月前
已完结
Celastrol attenuates Th17 cell response through downregulating HDAC3/FOXO3/GLS1-dependent glutaminolysis
1个月前
已完结
Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis
1个月前
已完结
Jianpi Jiedu formula modulates glutamine metabolism to inhibit colorectal cancer liver metastasis
1个月前
已完结
Ginsenoside compound K restrains hepatic fibrotic response by dual-inhibition of GLS1 and LDHA
1个月前
已完结
皖公网安备34019202002308
